Keyphrases
Mouse Model
100%
Multiple Myeloma
100%
Low-dose Cyclophosphamide
100%
Chemoimmunotherapy
100%
Treg
60%
Bone Marrow
40%
Tumor Cells
40%
Apoptosis
20%
Cell Population
20%
Repeated Administration
20%
Long Interval
20%
Paralysis
20%
Mode of Action
20%
Sick
20%
Disease Progression
20%
CD4 Cells
20%
Regulatory T Cell(Treg)
20%
Immune Tolerance
20%
Human Disease
20%
Cyclophosphamide Treatment
20%
Cyclophosphamide
20%
B-cell Malignancies
20%
Tumor-bearing Mice
20%
Dendritic Cells
20%
Alkylating Agents
20%
Recurrent Disease
20%
Immunostimulation
20%
Tumor Load
20%
Interleukin-2
20%
Bcl-xL
20%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
20%
Multiple Myeloma Progression
20%
NKT Cells
20%
Clonal Proliferation
20%
High-dose Cyclophosphamide
20%
Chemotherapeutic Regimens
20%
Malignant Plasma Cells
20%
Hind Limb Paralysis
20%
Immunology and Microbiology
Mouse Model
100%
Multiple Myeloma
100%
Cyclophosphamide
100%
Low Drug Dose
85%
Regulatory T Cell
71%
Tumor Cell
28%
Maturation
14%
B Cell
14%
CD4
14%
Immune Tolerance
14%
Downregulation
14%
Cell Population
14%
Drug Megadose
14%
Blood Plasma
14%
Dendritic Cell
14%
Immunostimulation
14%
Repeated Drug Dose
14%
CTLA-4
14%
Limb
14%
Interleukin 2
14%
Natural Killer T Cell
14%
Immunoglobulin Producing Cell
14%
Programmed Cell Death
14%